nimustine
Sign in to saveNimustine () is a nitrosourea alkylating agent.
Research
951 papers- Therapeutic effect of nimustine in a dog with intracranial histiocytic sarcoma.Open veterinary journal · 2024
- Nimustine Treatment of 11 Cases of Canine Histiocytic Sarcoma.Journal of the American Animal Hospital Association · 2020
- Retrospective evaluation of nimustine use in the treatment of feline lymphoma.Veterinary medicine and science · 2022
- Local Delivery of Nimustine Hydrochloride against Brain Tumors: Basic Characterization Study.The Tohoku journal of experimental medicine · 2023
- Regression of Recurrent Spinal Cord High-Grade Glioma After Convection-Enhanced Delivery of Nimustine Hydrochloride: Case Reports and Literature Review.Operative neurosurgery (Hagerstown, Md.) · 2020
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 272.078851
- Has use
- medication
Show 4 more facts
- chemical formula
- C₉H₁₃ClN₆O₂
- canonical SMILES
- CC1=NC=C(C(=N1)N)CNC(=O)N(CCCl)N=O
- Commons category
- Nimustine
- subject has role
- antineoplastic
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Nimustine () is a nitrosourea alkylating agent.
It is used to treat malignant brain tumors and has proven to be rather effective.
Excerpted from Wikipedia’s “nimustine” article, available under the CC BY-SA 4.0 licence.
Available in 8 languages
via Wikidata sitelinks · CC0